B. Metzler Seel. Sohn & Co. Holding Ag Dexcom Inc Transaction History
B. Metzler Seel. Sohn & Co. Holding Ag
- $10.1 Trillion
- Q3 2024
A detailed history of B. Metzler Seel. Sohn & Co. Holding Ag transactions in Dexcom Inc stock. As of the latest transaction made, B. Metzler Seel. Sohn & Co. Holding Ag holds 22,578 shares of DXCM stock, worth $1.68 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
22,578
Previous 32,026
29.5%
Holding current value
$1.68 Million
Previous $17.5 Million
8542.89%
% of portfolio
0.02%
Previous 0.25%
Shares
5 transactions
Others Institutions Holding DXCM
# of Institutions
1,044Shares Held
354MCall Options Held
4.08MPut Options Held
3.81M-
Vanguard Group Inc Valley Forge, PA47.4MShares$3.53 Billion0.06% of portfolio
-
Black Rock Inc. New York, NY34.5MShares$2.57 Billion0.09% of portfolio
-
Capital Research Global Investors Los Angeles, CA17.9MShares$1.33 Billion0.26% of portfolio
-
State Street Corp Boston, MA16.3MShares$1.21 Billion0.08% of portfolio
-
Baillie Gifford & CO15MShares$1.12 Billion0.77% of portfolio
About DEXCOM INC
- Ticker DXCM
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 386,257,984
- Market Cap $28.7B
- Description
- DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...